Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Guardant Health, Inc. (GH)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 121,380,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 2,187 2,187 5,168 98,220
Total Buy Value $38,963 $38,963 $136,461 $2,585,297
Total People Bought 1 1 1 2
Total Buy Transactions 1 1 2 4
Total Shares Sold 100 6,000 10,991 31,616
Total Sell Value $1,905 $157,493 $334,111 $1,291,105
Total People Sold 1 2 2 3
Total Sell Transactions 1 3 6 11
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 671
  Page 12 of 27  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-08 4 AS $159.48 $19,751,186 D/D (122,846) 2,468,074     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-07 4 AS $156.75 $5,843,684 D/D (36,843) 2,590,920     -
   Kaul Samir Director   –       •      –    2021-04-05 4 AS $155.91 $792,789 I/I (5,000) 19,943     -
   Clark Ian T Director   –       •      –    2021-03-25 4 AS $132.09 $71,064 D/D (538) 4,643     -
   Clark Ian T Director   –       •      –    2021-03-25 4 OE $4.18 $2,249 D/D 538 5,181     -
   Meresman Stanley J Director   –       •      –    2021-03-10 4 AS $137.85 $680,152 D/D (4,934) 4,059     -
   Meresman Stanley J Director   –       •      –    2021-03-10 4 OE $5.94 $29,308 D/D 4,934 8,993     -
   Clark Ian T Director   –       •      –    2021-02-25 4 AS $154.00 $82,852 D/D (538) 4,643     -
   Clark Ian T Director   –       •      –    2021-02-25 4 OE $4.18 $2,249 D/D 538 5,181     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-11 4 AS $168.35 $1,114,042 I/I (6,613) 470,800     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-11 4 AS $162.81 $3,918,993 I/I (23,529) 477,413     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-11 4 AS $162.65 $33,771,358 D/D (202,251) 1,725,422     -
   Meresman Stanley J Director   –       •      –    2021-02-10 4 AS $162.71 $802,811 D/D (4,934) 4,059     -
   Meresman Stanley J Director   –       •      –    2021-02-10 4 OE $5.94 $29,308 D/D 4,934 8,993     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-10 4 AS $156.11 $1,398,054 I/I (8,689) 500,942     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-10 4 AS $156.11 $9,381,070 D/D (58,304) 1,927,673     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-09 4 AS $161.95 $2,455,231 I/I (15,069) 509,631     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-09 4 AS $161.96 $16,474,264 D/D (101,111) 1,985,632     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-08 4 AS $161.48 $2,243,679 I/I (13,817) 524,700     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-08 4 AS $161.49 $15,054,427 D/D (92,708) 2,086,743     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-05 4 AS $157.84 $4,866,462 I/I (30,084) 538,517     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-05 4 AS $157.84 $32,653,529 D/D (201,861) 2,179,451     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-04 4/A AS $158.76 $5,280,436 D/D (33,177) 2,381,657     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-04 4 AS $157.76 $1,106,512 I/I (6,970) 568,601     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-04 4 AS $157.76 $7,469,835 D/D (47,053) 2,381,312     -
  671 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 27
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us